PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights

Low Price Stocks in United States

Stocks by share price, each list showing the top 10 first and up to 100 companies, updated every day from PositoAI's data.

Stocks Under $5

1,022 companies in the US priced under $5; highest Positivity Score: Aterian, Inc., Dogwood Therapeutics, Inc., Massimo Group.

Stocks Under $10

1,497 companies in the US priced under $10; highest Positivity Score: Newegg Commerce, Inc., Aterian, Inc., Dogwood Therapeutics, Inc..

Stocks Under $20

2,071 companies in the US priced under $20; highest Positivity Score: Newegg Commerce, Inc., Aterian, Inc., Dogwood Therapeutics, Inc..

A low share price does not make a stock cheap: what matters is the company's value compared with its earnings and assets (P/E, P/B). Very low-priced stocks are often small, thinly traded and more volatile.

Questions

How many stocks are priced under $5 in the US?

1,022 companies in the US on PositoAI are priced under $5. The highest Positivity Scores among them: Aterian, Inc., Dogwood Therapeutics, Inc., Massimo Group.

How many stocks are priced under $10 in the US?

1,497 companies in the US on PositoAI are priced under $10. The highest Positivity Scores among them: Newegg Commerce, Inc., Aterian, Inc., Dogwood Therapeutics, Inc..

How many stocks are priced under $20 in the US?

2,071 companies in the US on PositoAI are priced under $20. The highest Positivity Scores among them: Newegg Commerce, Inc., Aterian, Inc., Dogwood Therapeutics, Inc..

Is a low share price a good sign?

A low share price does not make a stock cheap: what matters is the company's value compared with its earnings and assets (P/E, P/B). Very low-priced stocks are often small, thinly traded and more volatile.

A list appears only when at least 20 companies qualify, and a country appears once PositoAI covers enough of its companies. Each list is ordered by one figure from PositoAI's data; it is not a recommendation. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.